Michael Harris, chief executive officer of Biocomposites explores the threat of antibiotic resistance and how antibiotics are being used within the orthopaedics industry.
For World Heart Day Ian Bolland speaks to Johnson & Johnson and the University of Leicester about the effects of Atrial Fibrillation on healthcare systems and the technologies and measures that can be put into place to treat the condition.
Dr David Bruchof, product manager for Oil-free Industrial Compressors at CompAir, discusses a best practice approach to using compressed air systems in pharmaceutical manufacturing facilities.
Robert Gaertner, senior director of strategy for Veeva Vault Quality looks at the steps manufacturing companies need to take to improve their content management systems.
Ivor Campbell managing director of Stirlingshire-based Snedden Campbell explores the use of blood tests to diagnose cancer and questions whether the NHS’ latest approach is the right one.
David Leitham, senior vice president and general manager at software company AspenTech looks at why process analytical technology (PAT) is essential for the journey to Pharma 4.0.
Liz Ashall-Payne, founding CEO of digital health consultancy ORCHA assesses the pharma's potential for digital apps and what the industry needs to bear in mind.
Dr Paul Dunn, chair of the International Hologram Manufacturers Association (IHMA) considers why a product identifier initiative by itself cannot be considered an authentication solution under ISO 12931.
Subhro Mallik, senior vice president, head of Life Sciences, Infosys explores how advances in data and technology had help with the development of future drugs.
Joe Corrigan, head of Intelligent Healthcare, Cambridge Consultants part of Capgemini Invent, looks at how the medical and technology industries are colliding.
